A1 Refereed original research article in a scientific journal

The use of antibiotic-loaded bone cement and systemic antibiotic prophylactic use in 2,971,357 primary total knee arthroplasties from 2010 to 2020: an international register-based observational study among countries in Africa, Europe, North America, and Oceania




AuthorsLeta Tesfaye H, Fenstad Anne Marie, Lygre Stein Håkon L, Lie Stein Atle, Lindberg-Larsen Martin, Pedersen Alma B, W-Dahl Annette, Rolfson Ola, Bülow Erik, Ashforth James A, van Steenbergen Liza N, Nelissen Rob G H H, Harries Dylan, De Steiger Richard, Lutro Olav, Hakulinen Emmi, Mäkelä Keijo, Willis Jinny, Wyatt Michael, Frampton Chris, Grimberg Alexander, Steinbrück Arnd, Wu Yinan, Armaroli Cristiana, Molinari Marco, Picus Roberto, Mullen Kyle, Illgen Richard, Stoica Ioan C, Vorovenci Andreea E, Dragomirescu Dan, Dale Håvard, Brand Christian, Christen Bernhard, Shapiro Joanne, Wilkinson J Mark, Armstrong Richard, Wooster Kate, Hallan Geir, Gjertsen Jan-Erik, Chang Richard N, Prentice Heather A, Paxton Elizabeth W

PublisherTaylor & Francis

Publication year2023

JournalActa Orthopaedica

Journal name in sourceActa Orthopaedica

Volume94

First page 416

Last page425

DOIhttps://doi.org/10.2340/17453674.2023.17737

Web address https://doi.org/10.2340/17453674.2023.17737

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/180902482


Abstract

Background and purpose — Antibiotic-loaded bone cement (ALBC) and systemic antibiotic prophylaxis (SAP) have been used to reduce periprosthetic joint infection (PJI) rates. We investigated the use of ALBC and SAP in primary total knee arthroplasty (TKA). Patients and methods — This observational study is based on 2,971,357 primary TKAs reported in 2010–2020 to national/regional joint arthroplasty registries in Australia, Den-mark, Finland, Germany, Italy, the Netherlands, New Zealand, Norway, Romania, South Africa, Sweden, Switzerland, the UK, and the USA. Aggregate-level data on trends and types of bone cement, antibiotic agents, and doses and duration of SAP used was extracted from participating registries. Results — ALBC was used in 77% of the TKAs with variation ranging from 100% in Norway to 31% in the USA. Palacos R+G was the most common (62%) ALBC type used. The primary antibiotic used in ALBC was gentamicin (94%). Use of ALBC in combination with SAP was common practice (77%). Cefazolin was the most common (32%) SAP agent. The doses and duration of SAP used varied from one single preoperative dosage as standard practice in Bolzano, Italy (98%) to 1-day 4 doses in Norway (83% of the 40,709 TKAs reported to the Norwegian arthroplasty register). Conclusion — The proportion of ALBC usage in primary TKA varies internationally, with gentamicin being the most common antibiotic. ALBC in combination with SAP was common practice, with cefazolin the most common SAP agent. The type of ALBC and type, dose, and duration of SAP varied among participating countries.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2025-27-03 at 21:56